Patriot Scientific Corp. is a intellectual property licensing company with several patents, which design and development of microprocessor chips design. Its technologies are used in computers, cameras, printers, automotive and industrial devices. The company was founded on June 10, 1987 and is headquartered in Carlsbad, CA.

Company profile
Ticker
CPMV
Exchange
Website
CEO
Carlton Johnson
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Sana Biotechnology • Ginkgo Bioworks • Bio-Techne • Denali Therapeutics ...
Former names
PATRIOT SCIENTIFIC CORP
SEC CIK
Corporate docs
Subsidiaries
Mosaic ImmunoEngineering Development Company • Patriot Data Solutions Group, Inc. ...
IRS number
841070278
CPMV stock data
Investment data
Securities sold
Number of investors
Calendar
4 Aug 22
12 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | May 20 | May 19 | May 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 205.99K | 205.99K | 205.99K | 205.99K | 205.99K | 205.99K |
Cash burn (monthly) | 57.35K | 31.36K | 294.58K | 290.47K | 57.35K | 59.83K |
Cash used (since last report) | 83.11K | 45.44K | 426.88K | 420.94K | 83.11K | 86.7K |
Cash remaining | 122.88K | 160.55K | -220.89K | -214.94K | 122.88K | 119.29K |
Runway (months of cash) | 2.1 | 5.1 | -0.7 | -0.7 | 2.1 | 2.0 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 22 | Nicole Franziska Steinmetz | Convertible Note [object Object] | Other | Acquire J | No | No | 10000 | - | 10K | - |
18 Feb 22 | Robert Baffi | Convertible Note [object Object] | Other | Acquire J | No | No | 50000 | - | 50K | - |
18 Feb 22 | Robert L Garnick | Convertible Note [object Object] | Other | Acquire J | No | No | 50000 | - | 50K | - |
18 Feb 22 | King Steven W | Convertible Note [object Object] | Other | Acquire J | No | No | 20000 | - | 20K | - |
18 Feb 22 | Gloria Felcyn | Convertible Note [object Object] | Other | Acquire J | Yes | No | 25000 | - | 25K | - |
Institutional ownership, Q1 2022
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 4.01B |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Western Reserve University Case | 4.01B | $0 |
West Oak Capital | 1 | $0 |
Financial report summary
?Competition
Bristol-Myers Squibb • Pfizer • AMGEN • Astrazeneca • Nektar Therapeutics • Novartis • Sanofi • GSK • BioNTech SEContent analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
calendar, expedite, fifteen, foregoing, Holocom, Jonathan, month, Notwithstanding, Pokorski, redeem, redeemable, redeemed, thirty, transmitted
Removed:
absence, absolute, accurately, aim, assure, capitalization, implementation, implemented, maintained, predicted, promulgated, ranging, ratio, reduction, split, view
Financial reports
Current reports
8-K
Entry into a Material Definitive Agreement
12 Jul 22
8-K
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
5 May 22
8-K
Entry into a Material Definitive Agreement
22 Feb 22
8-K
Mosaic ImmunoEngineering Inc. Elects Biotechnology Industry Veteran Robert A. Baffi, Ph.D. to Its Board of Directors
15 Jun 21
8-K
Entry into a Material Definitive Agreement
10 May 21
8-K
Amendments to Articles of Incorporation or Bylaws
30 Dec 20
8-K
Material Modifications to Rights of Security Holders
1 Dec 20
8-K/A
Departure of Directors or Certain Officers
19 Nov 20
8-K/A
Index to Financial Statements
14 Oct 20
8-K
Patriot Scientific Corporation and Mosaic ImmunoEngineering Inc. Enter into Definitive Merger Agreement
25 Aug 20
Registration and prospectus
S-1
IPO registration
3 Feb 22
S-8
Registration of securities for employees
9 Mar 21
S-3/A
Shelf registration (amended)
21 Jan 21
S-3
Shelf registration
10 Dec 20
D
$3.75K in options / securities to be acquired, sold $3.75K, 1 investor
25 Jan 10
S-8
Registration of securities for employees
1 Apr 09
S-8
Registration of securities for employees
27 Mar 08
POS AM
Prospectus update (post-effective amendment)
25 Dec 07
SB-2/A
Registration of securities for small business issuer (amended)
1 Apr 07
SB-2/A
Registration of securities for small business issuer (amended)
20 Mar 07
Other
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
24 Jan 21
CORRESP
Correspondence with SEC
20 Jan 21
UPLOAD
Letter from SEC
20 Dec 20
CT ORDER
Confidential treatment order
25 Sep 16
CT ORDER
Confidential treatment order
4 Jan 15
CT ORDER
Confidential treatment order
15 Sep 14
CT ORDER
Confidential treatment order
13 Feb 13
NO ACT
No action letter
17 Oct 10
NO ACT
No action letter
28 Sep 10
Ownership
4
Mosaic ImmunoEngineering / STEVEN W KING ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / GLORIA FELCYN ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / ROBERT L GARNICK ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / ROBERT BAFFI ownership change
22 Feb 22
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
22 Feb 22
3
Mosaic ImmunoEngineering / ROBERT BAFFI ownership change
16 Jul 21
4
Mosaic ImmunoEngineering / ROBERT L GARNICK ownership change
10 May 21
4
Mosaic ImmunoEngineering / GLORIA FELCYN ownership change
10 May 21
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
30 Apr 21
4
Mosaic ImmunoEngineering / Nicole Franziska Steinmetz ownership change
29 Jan 21